English

%e3%82%b9%e3%83%bc%e3%83%91%e3%83%bc%e3%82%b0%e3%83%ab%e3%83%bc%e6%b2%bb%e7%99%82

 Chinese  /  日本語

English

The Super glue system is a unique method of treating varicose veins which does not require anesthesia or compression garments. It differs from other vein treatments such as LASER CTEV or sclerotherapy in that it uses medical glue to close the vein.

What are Varicose Veins?

Varicose veins are those large, protruding veins which often appear on the legs. Varicose veins are not necessary for any bodily function, and can be eliminated through a variety of methods. Super glue is the latest advance in the treatment of varicose veins. Tokyo vein center clinic is a experts in vein treatments, and offer the latest and most advanced methods of reduction and elimination.

  • Leg pain, cramping
  • Leg  swelling
  • Leg heaviness or fatigue
  • Skin changes
  • Ulcers, sores, open wounds

 

How Does Super glue Work?

Super glue is a noninvasive vein closure system which uses a medical glue to close the affected vein, thus rerouting blood into healthy veins and eliminating the varicose vein. Super glue has been proven safe through clinical trials in the United States, and already has a proven track record in Europe.

Super glue uses ultrasound imagery to guide a tiny catheter into the varicose vein and deposit a small amount of safe for the body medical glue to close the vein. After the vein is closed, the blood is rerouted into healthy veins and the varicose vein will disappear. Super glue requires only a local anesthetic at the injection site – no need for tumescent anesthesia. Patients can leave the office immediately following a treatment, and there is generally no need to wear compression garments, although whether or not compression garments are needed will depend on the individual patient and their situation. 

Benefits of Super glue

Many patients appreciate that there is often no need to wear uncomfortable compression garments following a Super glue treatment, and there is generally not even a need for post-treatment pain medication.

  1. Quick – most procedures can be completed in just 20 minutes in the office setting
  2. Effective – the procedural success rate is 97%
  3. Painless – the VenaSeal procedure requires only a single injection of local anesthetic
  4. Minimally Invasive – patients can resume activity immediately
  5. No wait time – VenaSeal does not require a trial of compression socks prior to the procedure

Contact Tokyo Vein Center Clinic for a Super glue Consultation

 If you are suffering from varicose veins, there are treatments available which can help! If you think you may be a candidate for the brand-new Super glue varicose vein treatment, don’t hesitate to contact Tokyo Vein Center Clinic today to schedule your consultation! information@tokyokekkan.com

 

Next,  learn more about LASER CTEV, another similar option to treat your veins!

2016-08-07-13-30-59

venaseal-6

 

2016-08-07-13-30-07

information:

<Super Glue is  now available   50 vein clincs  in US and all over the world.>

http://www.myveins.co.uk/sapheon_VenaSeal.htm(UK)

http://www.lowellkabnickmd.com/vein-disease-treatments/the-venaseal-closure-system/ (USA)

http://www.fitzgibbonsveincenter.com/los-angeles-vein-treatment/venaseal/

 

<Clinical Paper>

A prospective comparison of a new cyanoacrylate glue and laser ablation for the treatment of venous insufficiency

  1. Ahmet Kürşat Bozkurt1
  2. Muhammet Fatih Yılmaz2

  1. 1Istanbul University Cerrahpaşa Medical Faculty, Istanbul, Turkey

  2. 2Department of Cardiovascular Surgery, Kayseri Research and Training Hospital, Kayseri, Turkey
  1. Ahmet Kürşat Bozkurt, Hakkı Yeten Caddesi Terrace Fulya No: 13 Center 2K: 5, D: 10, Fulya, Şişli, İstanbul, Turkey. Email: akbozkurt@yahoo.com

Abstract

Introduction Cyanoacrylate ablation is the newest nonthermal vein ablation technique. The one-year results of a prospective comparative study of a new cyanoacrylate glue versus endovenous laser ablation for the treatment of venous insufficiency is presented.

Material and methods A total of 310 adult subjects were treated with cyanoacrylate ablation or endovenous laser ablation. The primary endpoint of this study was complete occlusion of the great saphenous vein. Secondary endpoints were procedure time, procedural pain, ecchymosis at day 3, adverse events, changes from baseline in Venous Clinical Severity Score, and Aberdeen Varicose Vein Questionnaire.

Results Operative time was shorter (15 ± 2.5 versus 33.2 ± 5.7, <0.001), and periprocedural pain was less (3.1 ± 1.6 versus 6.5 ± 2.3, <0.001) in cyanoacrylate ablation group compared to the endovenous laser ablation group. Ecchymosis at the third day was also significantly less in cyanoacrylate ablation group (<0.001). Temporary or permanent paresthesia developed in seven patients in endovenous laser ablation group and none in cyanoacrylate ablation group (p = 0.015). One, three, and 12 months closure rates were 87.1, 91.7, and 92.2% for endovenous laser ablation and 96.7, 96.6, and 95.8% for cyanoacrylate ablation groups. Closure rate at first month was significantly better in cyanoacrylate ablation group (<0.001). Although there is a trend of better closure rates in cyanoacrylate ablation patients, this difference did not reach to the statistical difference at sixth and 12th month (p = 0.127 and 0.138, respectively). Both groups had significant improvement in Venous Clinical Severity Score and Aberdeen Varicose Vein Questionnaire postoperatively (<0.001), but there was no significant difference in Venous Clinical Severity Score and Aberdeen Varicose Vein Questionnaire scores between the groups at first, sixth, and 12 months. Only a slightly better well-being trend was noted in cyanoacrylate ablation group in terms of Aberdeen Varicose Vein Questionnaire scores (p = 0.062).

Conclusions The efficacy and safety analysis shows that cyanoacrylate ablation is a safe, simple method which can be recommended as an effective endovenous ablation technique. The follow-up data more than one year will clarify the future role of cyanoacrylate ablation for the treatment incompetent great saphenous veins.

VenaSeal – Closure: Results over 49 month

Summary

We report about newest results of a retrospective comparative study of VenaSeal – Closure in the treatment of 1228 saphenous veins (862 GSV, 360 SSV, 6 saphena – accessoria – inguinalis veins) in 687 cases. Treatment included also ulcera crures in 6 cases.

The present research paper sheds light on the advantages and disadvantages and presents the 49 – month results of an single-center ambulatory clinical study with retrospective design.

Introduction

Since 15 years by now, varicosis has been increasingly treated endovenously. At the start, the rather inconvenient VNUS®Closure Plus procedure and the more convenient linear laser procedure were used, and these were followed in 2006/2007 by the bipolar RFITT® catheter, the VNUS®ClosureFast system and the radial laser. Thus, in the course of the last few years, plenty of experience has been gathered with endoluminal therapy, quality criteria have been defined and standards for the different techniques have been developed. In addition, 13 years ago, far from the beaten tracks of radio wave and laser, the development of a fascinatingly simple, yet nevertheless highly effective method of gluing veins – the VenaSeal® closure technique – was initiated. After CE approval had been granted in the autumn of 2011, a number of vein centers in Germany and Europe started using the VenaSeal® system. By now, 17 centers are working successfully with the new therapy system in Germany alone.

The author has applied Venaseal for the first time in a great saphenous vein on 1st. August 2012.

Results

Over the course of 49 months of application of the VenaSeal® system, permanent complete closure of the treated vein could be verified by means of duplex sonography in 1195 veins (97,3%).

On the 1st day 1228 saphenous veins were checked (1217 were closed initially = 99,1%) in the scope of follow-up, and up to the 30th day, partial recanalization was found in 24 veins, and complete recanalization was found in 4 veins. This corresponds to a closure rate of 97,6%

Over a time period of 3 months up to now, we were able to follow up 975 saphenous veins (79,4 % of all veins that had been treated), and here we found 24 partial and 6 complete recanalizations. The closure rate is thus 97,5%

905 saphenous veins (73,7%) were followed up over a 6-month time period, and 24 partial and 9 complete recanalizations were found, resulting in an effectiveness of 97.3%.

No further recanalizations were found after a 37-month follow-up period in 700 saphenous veins (57%) up to now.

All leg ulceras were healed until to 14 days after intervention.

1228 veins having been glued with Venaseal®, the results achieved over the entire time period of 49 months are equivalent to a closure rate of 97.3%.

Side effects

The pain score for subjectively felt pain on the 1st. day post-surgery (range 1-10) was between 1 and 3 (2.1) – in RFITT 3-8 = 4,1). In 163 treated veins (13,3%), we observed a postoperative unspecific inflammatory skin reaction after approx. 10 – 14 days in the Venaseal group; with appropriate antiphlogistic treatment with ibuprofen and cooling dressings, this subsided within 3-5 days.

In all other cases subjected to follow-up examinations, no complications of any kind, no paresthesias or hypesthesias, no permanent skin reactions, no phlebitis or thrombosis or infections were observed. Only in three cases we were seen a lymphatic fistula at the peripherial punktion.

In particular, even subcutaneously situated saphenous veins could be glued without any significant skin reaction (reddening, swelling). We also clearly prefer VenaSeal® in treatment of SSV, Due to the large number of neurological sensations in connection with treatment by Laser and Radiofrequency.

Nearly all patients were greatly surprised at the fully ambulatory intraoperative procedure and the brief and pleasant postoperative convalescence phase.

All patients were able to leave the office between 30 and 120 minutes after the intervention.

In the case of VenaSeal, we have up to now refrained from applying compression therapy in 97 % of all cases. We prefer to use compression stockings only in cases, the diameter of the treated vein ist over 1,5 cm or in treatment of venous aneurysm or ectatic varicous veins.

%e3%82%b0%e3%83%ab%e3%83%bc%e7%8f%be%e4%bb%a3-700